Showing results (131-140 of 148) with videos related to
Sort By:
Pageof 15
Molecular and Clinical Oncology|March 21, 2014
A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancerHidehiro Tajima, Hirohisa Kitagawa, Tomoya Tsukada, et al.Experimental and Therapeutic Medicine|September 13, 2012
Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancerHidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.Experimental and Therapeutic Medicine|September 15, 2012
Pilot study of hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for patients with postoperative liver metastases from pancreatic cancerHidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.Molecular and Clinical Oncology|May 23, 2017
Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancerHidehiro Tajima, Tetsuo Ohta, Hiroyuki Shinbashi, et al.Oncology Letters|July 12, 2012
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44Hidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.Oncology Letters|October 19, 2013
Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell lineAtsushi Hirose, Hidehiro Tajima, Tetsuo Ohta, et al.Oncology Reports|July 7, 2012
Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancerKatsuhiro Yoshimoto, Hidehiro Tajima, Tetsuo Ohta, et al.Journal of Gastroenterology|February 22, 2014
Evaluation of serum HER2-ECD levels in patients with gastric cancerKatsunobu Oyama, Sachio Fushida, Tomoya Tsukada, et al.Oncology Reports|May 27, 2014
Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancerJun Kinoshita, Sachio Fushida, Tomoya Tsukada, et al.Journal of Surgical Oncology|January 27, 2026
Original Study: Risk Factors for Early Recurrence in Patients With Biliary Tract Cancers Who Underwent Curative Resection: An Exploratory Subgroup Analysis of JCOG1202Hiroaki Yanagimoto, Kohei Nakachi, Masafumi Ikeda, et al.Pageof 15